CompletedPhase 1NCT00093821
Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Studying Desmoplastic small round cell tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Tanya Trippett, MDMemorial Sloan Kettering Cancer Center
- Intervention
- tanespimycin(drug)
- Enrollment
- 70 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2004
Study locations (1)
- Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00093821 on ClinicalTrials.govOther trials for Desmoplastic small round cell tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07328425Clinical Study in Patients With DSRCTItalian Sarcoma Group
- RECRUITINGPHASE2NCT06456359Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell TumorUniversity Hospital Heidelberg
- RECRUITINGPHASE1, PHASE2NCT05918640Lurbinectedin in FET-Fused TumorsChildren's Hospital of Philadelphia
- RECRUITINGNCT04690374Registry to Collect Health Information About Desmoplastic Small Round Cell TumorMemorial Sloan Kettering Cancer Center
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04145349CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell TumorEli Lilly and Company
- ACTIVE NOT RECRUITINGPHASE2NCT04022213A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the PeritoneumMemorial Sloan Kettering Cancer Center
- ACTIVE NOT RECRUITINGPHASE2NCT01946529Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell TumorsSt. Jude Children's Research Hospital
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT01189643Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell TumorMemorial Sloan Kettering Cancer Center